SAN MATEO, Calif., Nov. 9, 2011 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (Nasdaq:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at Lazard Capital Markets 8th Annual Healthcare Conference to be held November 15-16, 2011, at the Pierre Hotel in New York, NY. Mr. DiTonno, as well as Stephen Ghiglieri, Chief Financial Officer, will be available to respond to questions and participate in one-on-one meetings with investors.
